Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Healthcare Medical Devices
Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Lexagene Holdings Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(78)
•••
Post by Chopper1BigDogon Aug 14, 2020 5:38am
119 Views
Post# 31406995

NEW HIRE - THIS GIRL I HEAR IS GOOD - PROVEN SALES

NEW HIRE - THIS GIRL I HEAR IS GOOD - PROVEN SALES

New Hire For Lex - FDA COMING SOON 

Just In Case any one missed the post about the New Hire 

Meet Lexagenes New Director Of Clinical Sales

Here's Lexagenes new Director of Clinical Sales,looks like she has a tremendous track record and great experience working with the largest bio tech companies 

What a fantastic addition to sell MiQLab for Lexagene

She obviously sees LexGene as being a major player in the Bio Testing Market and must be really impressed with MiQLab

i don't think you would be hiring a human clinical sales Director unless you were pretty sure you would be entering the human clinical diagnostics market very soon

I bet her contact list is quite special 

Great News


https://www.linkedin.com/in/amyfraga


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities